The US soft tissue repair market is expected to grow 8% per year from $1.05 billion in 2009 to over $1.9 billion in 2016. Hoping to capitalize on this growth, T.A.G. exports 99% of its production to prime customers such as DePuy Mitek, Inc. (a Johnson & Johnson company), Stryker Corporation, and Tornier, Inc.

T.A.G.'s experience and streamlined research and development process places the company in a prime position for growth within the field of sports medicine. The firm has developed eighteen families of inventions that are either patented or patent-pending. In addition, T.A.G's products have gained worldwide regulatory and quality certifications including FDA and CE approvals.

According to Ran Ben-Or, a partner in Tene Investment Funds: "Tene identified T.A.G. as suitable to its investment strategy in companies which present innovation and excellence in a quickly growing global market. Tene is looking forward to helping the company realize its vast business potential in cooperation with the company's management and with the Kibbutz."